Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...

Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Both Zepbound and Ozempic can lead to weight loss, but only Zepbound is FDA-approved for weight loss. Zepbound treats obesity and obstructive sleep apnea; Ozempic treats type 2 diabetes and lowers ...

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...

Millions of patients taking GLP-1 receptor agonists such as semaglutide have achieved dramatic weight loss, but a growing ...

U.S. Food and Drug Administration (FDA) approved Wegovy pill from Novo Nordisk. The pill will contain 25 mg of ...

Structure Therapeutics (NASDAQ:GPCR) shared new top-line results from its ACCESS II clinical program for aleniglipron, an ...

Couples who lose weight together stay together. It might not be exactly how the saying goes, but it should be. Losing weight ...

A science-based weight loss protocol designed to help men lose fat, preserve muscle, and improve metabolic health ...